Methode reported a quarterly loss of $0.30 per share, wider than the Zacks Consensus Estimate of a $0.11 loss. The result was still an improvement from a $0.77 per-share loss in the same quarter last year, indicating year-over-year earnings progress despite missing expectations.
Methode reported a quarterly loss of $0.30 per share, wider than the Zacks Consensus Estimate of a $0.11 loss. The result was still an improvement from a $0.77 per-share loss in the same quarter last year, indicating year-over-year earnings progress despite missing expectations.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately negative
Sentiment Score
-0.30
